{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:47:02Z","timestamp":1781754422138,"version":"3.54.5"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Sepsis syndromes are a major burden in the ICU with very high mortality. Vasopressin and copeptin are released in response to hypovolemia and have shown potential significance in diagnosing sepsis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>To investigate the levels of copeptin in patients with sepsis syndromes and evaluate its relation with patient prognosis and mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Four databases were searched for literature published from inception to the 8th of November 2022. Original research articles where copeptin was measured in sepsis patients and compared with controls were included. Data extraction and synthesis: study characteristics, levels of copeptin in the participants, and copeptin assay description were extracted. Levels of copeptin in patients were pooled and compared with controls in terms of the standard mean difference (SMD) generated using a random-effects model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Fifteen studies met the selection criteria. Copeptin levels were significantly higher in patients with sepsis, severe sepsis, and septic shock as compared to controls [(SMD: 1.49, 95% CI: 0.81\u20132.16, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.0001), (SMD: 1.94, 95% CI: 0.34\u20133.54, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.02), and (SMD: 2.17, 95% CI: 0.68\u20133.66, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.004), respectively]. The highest copeptin levels were noted in septic shock patients. The admission copeptin levels were significantly lower in survivors as compared to nonsurvivors (SMD: \u22121.73; 95% CI: \u22122.41 to \u22121.06, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion and Relevance:<\/jats:title>\n            <jats:p>Copeptin was significantly elevated in sepsis, severe sepsis, and septic shock. Survivors had a significantly lower copeptin during admission. Copeptin offered an excellent predictability to predict 1-month mortality. Measuring the copeptin in sepsis patients can aid treating physicians to foresee patients\u2019 prognosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/js9.0000000000001069","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T17:02:02Z","timestamp":1713286922000},"page":"2355-2365","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Association of copeptin levels with patient prognosis and survival in sepsis syndromes: a meta-analysis"],"prefix":"10.1097","volume":"110","author":[{"given":"Abhinav","family":"Bhattarai","sequence":"first","affiliation":[{"name":"Institute of Medicine, Tribhuvan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangam","family":"Shah","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Tribhuvan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Baidya","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Tribhuvan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjana","family":"Thapa","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Tribhuvan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyog","family":"Bhandari","sequence":"additional","affiliation":[{"name":"Tribhuvan University Teaching Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eans T.","family":"Tuladhar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Institute of Medicine, Tribhuvan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash P.","family":"Acharya","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Sah","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal"},{"name":"Department of Microbiology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4]]},"reference":[{"key":"R1-20250824","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/bmj.39346.495880.AE","article-title":"Sepsis: definition, epidemiology, and diagnosis","volume":"335","author":"Lever","year":"2007","journal-title":"BMJ"},{"key":"R2-20250824","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jgar.2017.06.013","article-title":"Sepsis and septic shock: new definitions, new diagnostic and therapeutic approaches","volume":"10","author":"Esposito","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"R3-20250824","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"R4-20250824","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/sur.2020.047","article-title":"Sepsis and septic shock in low- and middle-income countries","volume":"21","author":"Stephen","year":"2020","journal-title":"Surg Infect (Larchmt)"},{"key":"R5-20250824","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s11739-021-02735-7","article-title":"Management of sepsis and septic shock in the emergency department","volume":"16","author":"Gavelli","year":"2021","journal-title":"Intern Emerg Med"},{"key":"R6-20250824","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"R7-20250824","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","article-title":"The timing of early antibiotics and hospital mortality in sepsis","volume":"196","author":"Liu","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-20250824","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","article-title":"Time to treatment and mortality during mandated emergency care for sepsis","volume":"376","author":"Seymour","year":"2017","journal-title":"N Engl J Med"},{"key":"R9-20250824","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jama.2018.9071","article-title":"Association between the New York sepsis care mandate and in-hospital mortality for pediatric sepsis","volume":"320","author":"Evans","year":"2018","journal-title":"JAMA"},{"key":"R10-20250824","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00134-018-5085-0","article-title":"The surviving sepsis campaign bundle: 2018 update","volume":"44","author":"Levy","year":"2018","journal-title":"Intensive Care Med"},{"key":"R11-20250824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2007.10.007","article-title":"Vasopressin: behavioral roles of an \u201coriginal\u201d neuropeptide","volume":"84","author":"Caldwell","year":"2008","journal-title":"Prog Neurobiol"},{"key":"R12-20250824","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0889-8529(05)70207-3","article-title":"Antidiuretic hormone. Normal and disordered function","volume":"30","author":"Robertson","year":"2001","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R13-20250824","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1172\/JCI107423","article-title":"Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma","volume":"52","author":"Robertson","year":"1973","journal-title":"J Clin Invest"},{"issue":"2 Pt 2","key":"R14-20250824","first-page":"I129","article-title":"Plasma and platelet vasopressin in essential hypertension and congestive heart failure","volume":"5","author":"Preibisz","year":"1983","journal-title":"Hypertension"},{"key":"R15-20250824","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2022.02.002","article-title":"Copeptin in fluid disorders and stress","volume":"529","author":"Mu","year":"2022","journal-title":"Clin Chim Acta"},{"key":"R16-20250824","doi-asserted-by":"crossref","first-page":"901990","DOI":"10.3389\/fcvm.2022.901990","article-title":"Copeptin as a diagnostic and prognostic biomarker in cardiovascular diseases","volume":"9","author":"Mu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R17-20250824","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1210\/jc.2017-01891","article-title":"Release and decay kinetics of copeptin vs AVP in response to osmotic alterations in healthy volunteers","volume":"103","author":"Fenske","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-20250824","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin Chem"},{"key":"R19-20250824","doi-asserted-by":"crossref","first-page":"170437","DOI":"10.1016\/j.peptides.2020.170437","article-title":"Vasopressin and copeptin release during sepsis and septic shock","volume":"136","author":"Gomes","year":"2021","journal-title":"Peptides"},{"key":"R20-20250824","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11883-014-0421-5","article-title":"Copeptin-marker of acute myocardial infarction","volume":"16","author":"M\u00f6ckel","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"R21-20250824","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1210\/jc.2005-2830","article-title":"Copeptin and arginine vasopressin concentrations in critically ill patients","volume":"91","author":"Jochberger","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-20250824","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"R25-20250824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"R26-20250824","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2288-14-30","article-title":"Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference?","volume":"14","author":"Takeshima","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"R27-20250824","first-page":"109","article-title":"Endocrine And metabolic alterations may underlie mortality of severe sepsis and septic shock patients admitted to ICU","volume":"46","author":"Ameen","year":"2016","journal-title":"J Egypt Soc Parasitol"},{"key":"R28-20250824","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/2356-8062.200907","article-title":"The potential of serum copeptin as a prognostic marker of mortality in patients with sepsis, severe sepsis, or septic shock","volume":"2","author":"Assaad","year":"2016","journal-title":"Egypt J Obesity, Diabetes Endocrinol"},{"key":"R29-20250824","doi-asserted-by":"crossref","first-page":"3624730","DOI":"10.1155\/2016\/3624730","article-title":"Assessment of diagnostic and prognostic role of copeptin in the clinical setting of sepsis","volume":"2016","author":"Battista","year":"2016","journal-title":"Biomed Res Int"},{"key":"R30-20250824","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/0300060514561136","article-title":"Plasma concentrations of copeptin, C-reactive protein and procalcitonin are positively correlated with APACHE II scores in patients with sepsis","volume":"43","author":"Jiang","year":"2015","journal-title":"J Int Med Res"},{"key":"R31-20250824","doi-asserted-by":"crossref","first-page":"e22614","DOI":"10.1002\/jcla.22614","article-title":"Clinical relevance of copeptin plasma levels as a biomarker of disease severity and mortality in critically ill patients","volume":"32","author":"Koch","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"R32-20250824","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1530\/EC-21-0211","article-title":"Risk assessment of sepsis through measurement of proAVP (copeptin): a secondary analysis of the TRIAGE study","volume":"10","author":"Kloter","year":"2021","journal-title":"Endocr Connect"},{"key":"R33-20250824","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00134-013-2825-z","article-title":"Vasopressin and copeptin levels in children with sepsis and septic shock","volume":"39","author":"Lee","year":"2013","journal-title":"Intensive Care Med"},{"key":"R34-20250824","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/cc9102","article-title":"Proven infection-related sepsis induces a differential stress response early after ICU admission","volume":"14","author":"Lesur","year":"2010","journal-title":"Crit Care"},{"key":"R35-20250824","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/SHK.0b013e318033e5da","article-title":"Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock","volume":"28","author":"Morgenthaler","year":"2007","journal-title":"Shock"},{"key":"R36-20250824","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.peptides.2014.07.011","article-title":"Copeptin as a diagnostic biomarker for sepsis-related deaths","volume":"59","author":"Palmiere","year":"2014","journal-title":"Peptides"},{"key":"R37-20250824","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2431-11-38","article-title":"Copeptin concentration in cord blood in infants with early-onset sepsis, chorioamnionitis and perinatal asphyxia","volume":"11","author":"Schlapbach","year":"2011","journal-title":"BMC Pediatr"},{"key":"R38-20250824","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/j.peptides.2005.04.019","article-title":"Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients","volume":"26","author":"Struck","year":"2005","journal-title":"Peptides"},{"key":"R39-20250824","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00134-014-3468-4","article-title":"Prognostic significance of hypothalamic-pituitary-adrenal axis hormones in early sepsis: a study performed in the emergency department","volume":"40","author":"Zhang","year":"2014","journal-title":"Intensive Care Med"},{"key":"R40-20250824","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/1687-4625.195893","article-title":"Prognostic value of the biomarker copeptin in critically ill patients with sepsis","volume":"22","author":"Sobhy","year":"2016","journal-title":"Kasr Al Ainy Med J"},{"key":"R41-20250824","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12879-021-07012-8","article-title":"Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock: a prospective observational study according to the Sepsis-3 definitions","volume":"22","author":"Lee","year":"2022","journal-title":"BMC Infect Dis"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000001069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T19:02:31Z","timestamp":1756062151000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000001069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,17]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000001069","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,17]]},"assertion":[{"value":"2023-08-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}